A detailed history of Cx Institutional transactions in Zoetis Inc. stock. As of the latest transaction made, Cx Institutional holds 8,142 shares of ZTS stock, worth $1.32 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares
8,142
Previous 7,660 6.29%
Holding current value
$1.32 Million
Previous $1.33 Million 19.82%
% of portfolio
0.07%
Previous 0.06%

Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 11, 2024

BUY
$172.58 - $196.48 $83,183 - $94,703
482 Added 6.29%
8,142 $1.59 Million
Q2 2024

Jul 11, 2024

BUY
$145.54 - $178.83 $121,380 - $149,144
834 Added 12.22%
7,660 $1.33 Million
Q1 2024

Apr 15, 2024

SELL
$165.67 - $199.94 $106,691 - $128,761
-644 Reduced 8.62%
6,826 $1.16 Million
Q4 2023

Jan 12, 2024

SELL
$151.44 - $200.09 $51,641 - $68,230
-341 Reduced 4.37%
7,470 $1.47 Million
Q3 2023

Oct 17, 2023

SELL
$167.14 - $192.77 $896,706 - $1.03 Million
-5,365 Reduced 40.72%
7,811 $1.36 Million
Q2 2023

Jul 26, 2023

BUY
$160.94 - $186.23 $22,209 - $25,699
138 Added 1.06%
13,176 $2.27 Million
Q1 2023

May 04, 2023

BUY
$145.48 - $175.02 $1.49 Million - $1.79 Million
10,240 Added 365.98%
13,038 $2.17 Million
Q4 2022

Feb 03, 2023

BUY
$131.14 - $157.47 $156,056 - $187,389
1,190 Added 74.0%
2,798 $410,000
Q3 2022

Nov 04, 2022

BUY
$148.29 - $182.55 $18,981 - $23,366
128 Added 8.65%
1,608 $238,000
Q2 2022

Aug 02, 2022

SELL
$155.97 - $200.09 $43,515 - $55,825
-279 Reduced 15.86%
1,480 $254,000
Q1 2022

May 09, 2022

BUY
$181.39 - $234.03 $23,580 - $30,423
130 Added 7.98%
1,759 $332,000
Q4 2021

Jan 18, 2022

SELL
$193.69 - $247.03 $330,435 - $421,433
-1,706 Reduced 51.15%
1,629 $398,000
Q3 2021

Nov 10, 2021

SELL
$189.29 - $209.69 $1.73 Million - $1.92 Million
-9,160 Reduced 73.31%
3,335 $647,000
Q2 2021

Aug 04, 2021

BUY
$155.9 - $187.99 $46,925 - $56,584
301 Added 2.47%
12,495 $2.33 Million
Q1 2021

Apr 15, 2021

BUY
$144.0 - $169.39 $1.6 Million - $1.88 Million
11,128 Added 1043.9%
12,194 $1.92 Million
Q4 2020

Jan 12, 2021

SELL
$157.07 - $174.35 $22,303 - $24,757
-142 Reduced 11.75%
1,066 $176,000
Q3 2020

Oct 13, 2020

BUY
$137.1 - $165.37 $36,605 - $44,153
267 Added 28.37%
1,208 $200,000
Q2 2020

Aug 06, 2020

BUY
$111.92 - $142.53 $23,615 - $30,073
211 Added 28.9%
941 $129,000
Q1 2020

Apr 29, 2020

BUY
$92.66 - $144.94 $926 - $1,449
10 Added 1.39%
730 $86,000
Q3 2019

Oct 10, 2019

BUY
$112.57 - $128.43 $1,688 - $1,926
15 Added 2.13%
720 $90,000
Q2 2019

Jul 17, 2019

BUY
$97.98 - $114.28 $1,077 - $1,257
11 Added 1.59%
705 $80,000
Q1 2019

Apr 03, 2019

BUY
$81.56 - $100.67 $15,170 - $18,724
186 Added 36.61%
694 $70,000
Q4 2018

Jan 14, 2019

BUY
$79.28 - $95.27 $1,664 - $2,000
21 Added 4.31%
508 $43,000
Q2 2018

Jul 12, 2018

BUY
$79.9 - $89.2 $38,911 - $43,440
487 New
487 $41,000

Others Institutions Holding ZTS

About Zoetis Inc.


  • Ticker ZTS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 468,139,008
  • Market Cap $76.1B
  • Description
  • Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...
More about ZTS
Track This Portfolio

Track Cx Institutional Portfolio

Follow Cx Institutional and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cx Institutional, based on Form 13F filings with the SEC.

News

Stay updated on Cx Institutional with notifications on news.